4McCullough P A. Evaluation and treatment of coronary artery disease in patients with end-stage renal disease [ J]. Kidney Int Suppl, 2005, (95) : S51 -S58.
5Floege j, Ketteler M. Vascular calcification in patients with end-stage renal disease[J]. Nephrol Dial Transplant, 2004, (19 Suppl 5) : Ⅴ59 - Ⅴ66.
6White A P, Vaccaro A R, Hall J A, et al. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion [ J]. Int Orthop, 2007, 31(6): 735-741.
7Sarnak M J, Levey A S, Schoolwerth A C, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention [ J ]. Circulation,2003,8:2154 - 2169.
8Devereux R B, Alonso D R, Lotas E M et al. Echocardiographic assessment of left ventricular hypertrophy, comparision to necropsy findings[ J]. AM J Cardial, 1986,57:54.
9Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease [J]. Nephrol Dial Transplant, 2003, 18 (17) : 229.
10Devereux RB,Alomo DR,Lotas EM,et al.Eeboeardio-graphic assessment of left ventrieular hypertrophycomparision to necropsy findings[J].AMJ Cardial,1986,57:54.
